Alliance Pharma PLC (GB:APH)
LSE:APH
Holding GB:APH?
Track your performance easily

Alliance Pharma (APH) Financial Statements

46 Followers

Alliance Pharma Financial Overview

Alliance Pharma's market cap is currently ―. The company's EPS TTM is p-0.062; its P/E ratio is -8.06; Alliance Pharma is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is p0.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 31.71M£ 29.38M£ 29.06M£ 27.39M£ 28.90M
Total Assets£ 537.41M£ 548.57M£ 503.49M£ 513.96M£ 508.85M
Total Debt£ 137.58M£ 136.24M£ 118.94M£ 136.49M£ 142.02M
Net Debt£ 105.86M£ 106.86M£ 89.88M£ 109.10M£ 113.13M
Total Liabilities£ 249.75M£ 251.64M£ 221.00M£ 233.79M£ 227.90M
Stockholders Equity£ 287.66M£ 296.93M£ 282.49M£ 280.17M£ 280.96M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Alliance Pharma Earnings and Revenue History

Alliance Pharma Debt to Assets

Alliance Pharma Cash Flow

Alliance Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis